Management of canine pituitary-dependent hyperadrenocorticism with 1-deprenyl (anipryl)

Veterinary Clinics of North America - Small Animal Practice

Volumn 27, Issue 2, 1997, Pages

  Bruyette, D S ^a   Ruehl, W W ^a   Entriken, T ^a   Griffin, D ^a   Darling, L ^a  

^a VCA West Los Angeles   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELEGILINE; UNCLASSIFIED DRUG;

DOG; DRUG EFFICACY; HYPERADRENOCORTICISM; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW;

EID: 0031003125     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(97)50031-3     Document Type: Review

References (34)

1. M. Berry D.S. Bruyette A retrospective study of pituitary and adrenal neoplasia and the incidence of hyperadrenocorticism in a geriatric beagle colony J Vet Intern Med 8 1994 163
2. W. Birkmayer J. Knoll P. Riederer Increased life expectancy resulting from addition of 1-deprenyl to Madopar treatment in Parkinson's disease: A longterm study J Neural Transmission 64 1985 113 127
3. D.S. Bruyette W.W. Ruehl T.L. Smidberg Therapy of canine pituitary dependent hyperadrenocorticism with 1-deprenyl J Vet Intern Med 7 1993 114
4. D.S. Bruyette W.W. Ruehl T.L. Smidberg Canine pituitary dependent hyperadrenocorticism: A spontaneous animal model for neurodegenerative disorders and their treatment with 1-deprenyl Prog Brain Res 106 1995 207 215
5. D.B. Calne Treatment of Parkinson's disease N Engl J Med 329 1993 1021 1027
6. M. DeLeon T. McRae J. Tsai Abnormal Cortisol response in Alzheimer's disease linked to hippocampal atrophy Lancet 2 1988 391 392
7. T.S. Elizan (—)-Deprenyl combined with 1-dopa in the treatment of Parkinson's disease I. Szelenyi Inhibitors of Monoamine Oxidase B: Pharmacology and Clinical Use in Neurodegenerative Disorders 1993 Birkhauser Basel 277 289
8. G. Faglia Epidemiology and pathogenesis of pituitary adenomas Acta Endocrinol 129 1994 1 5
9. E.C. Feldman Adrenal gland disease S.J. Ettinger E.C. Feldman Textbook of Veterinary Internal Medicine ed 4 1994 WB Saunders Philadelphia 1538 1578
10. M. Gerlach P. Riederer M.H. Youdim The mode of action of MAO-B inhibitors I. Szelenyi Inhibitors of Monoamine Oxidase B: Pharmacology and Clinical Use in Neurodegenerative Disorders 1993 Birkhauser Basel 183 201
11. L.G. Jia B.J. Canny D.N. Orth Distinct classes of corticotropes mediate corticotropin-releasing hormone and arginine vasopressin-stimulated adrenocorticotropin release Endocrinology 128 1991 197 203
12. R.J. Kemppainen C.A. Zerbe J.L. Sartin Regulation and secretion of proopiomelanocortin peptides from isolated perfused dog pituitary pars intermedia cells Endocrinology 124 1989 2208 2217
13. R.J. Kemppainen T.P. Clark J.L. Sartin Regulation of the adrenocorticotropin secretion from cultured canine anterior pituitary cells Am J Vet Res 53 1992 2355 2358
14. P.P. Kintzer M.E. Peterson Mitotane (o, p'-DDD) treatment of 200 dogs with pituitary- dependent hyperadrenocorticism J Vet Intern Med 5 1991 182 190
15. S.W. Lamberts J.G. Klijn M. De Quijada The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome J Clin Endocrinol Metab 51 1980 307 311
16. S. Lupien A. LeCours I. Lussier Basal Cortisol levels and cognitive deficits in human aging J Neurosci 14 1994 2893 2903
17. J.C. Meijer G.H. Mulder A. Rijnberk Hypothalmic corticotrophin-releasing factor activity in dogs with pituitary-dependent hyperadrenocorticism J Endocrinol 79 1978 209213
18. J.C. Meijer R.M. Croughs A. Rijnberk Hypothalamic catecholamine levels in dogs with spontaneous hyperadrenocorticism Neuroendocrinol 32 1981 197 201
19. M. Mizobuchi T. Hineno Y. Kakimoto Increase of plasma adrenocorticotropic and Cortisol in l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP)-treated dogs Brain Res 612 1993 319 321
20. L.K. Nieman G.B. Cutler Cushing's syndrome L.J. DeGroot Endocrinology ed 3 1995 WB Saunders Philadelphia 1741 1770
21. Parkinson Study Group Effect of deprenyl on the progression of disability in early Parkinson's disease N Engl J Med 321 1989 1363 1371
22. Parkinson Study Group Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease N Engl J Med 328 1993 176 183
23. M.E. Peterson D.T. Krieger W.D. Drucker Immunocytochemical study of the hypophysis in 25 dogs with pituitary-dependent hyperadrenocorticism Acta Endocrinol 101 1982 15 24
24. M.E. Peterson M. Palkovits C.C. Chiueh Biogenic amine and corticotropin-releasing factor concentrations in hypothalamic paraventricular nucleus and biogenic amine levels in the median eminence of normal dogs, chronic dexamethasone treated dogs, and dogs with naturally occurring pituitary-dependent hyperadrenocorticism (canine Cushing's disease) J Neuroendocrinol 1 1989 169 171
25. I.A. Reid L. Chou D. Chang Role of dopamine in the inhibition of vasopressin secretion by 1-dopa in carbidopa-treated dogs Hypertension 8 1986 890 896
26. A. Rijnberk J.A. Mol M.M. Kwant Effects of bromocriptine on corticotrophin, melanotrophin, and corticosteroid secretion in dogs with pituitary-dependent hyperadrenocorticism J Endocrinol 118 1988 271 277
27. J. Rothuizen J.M. Reul A. Rijnberk Aging and the hypothalamus-pituitary-adrenocortical axis, with special reference to the dog Acta Endocrinol (Copenh) 125 1991 73 76
28. W.W. Ruehl D.S. Bruyette A. DePaoli Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: Clinical presentation, cognitive testing, pathology and response to 1-deprenyl therapy Prog Brain Research 106 1995 217 225
29. R.M. Sapolsky Why stress is bad for your brain Science 273 1996 749 750
30. B. Sharp R. Ross E. Levin Dopamine regulates canine plasma β-endorphin immunoreactivity levels Endocrinology 110 1982 1828 1830
31. R. Stolp H.M. Steinbusch A. Rijnberk Organization of ovine corticotropin-releasing factor immunoreactive neurons in the canine hypothalamo-pituitary system Neurosci Lett 74 1987 337 342
32. W.G. Tatton C.E. Greenwood Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism J Neurosci Res 30 1991 666 672
33. P.A. Van Wijk A. Rijnberk R.M. Croughs Corticotrophin-releasing hormone and adrenocorticotropic hormone concentrations in cerebrospinal fluid of dogs with pituitary-dependent hyperadrenocorticism Endocrinology 231 1992 2659 2662
34. C.A. Zerbe T.P. Clark J.L. Sartin Domperidone treatment enhances corticotropin releasing hormone stimulated ACTH release from the dog pituitary Neuroendocrinology 57 1993 282 288